Articles

Clinical testing of new drug candidates is an increasingly complex, lengthy and expensive process with a dauntingly expensive price tag. Companies developing pharmaceutical products face mounting pressure to increase the efficiency of the drug evaluation process, particularly in the clinical stages...

Like divorces in Hollywood, clinical drug trials can be long, messy, expensive affairs. So when Dr. Michael Bowden, a pharmaceutical researcher, was put in charge of testing a promising new treatment for Alzheimers, he looked for ways to cut time and money...

Pharmaceutical outsourcing of clinical development to traditional CROs has grown steadily in the past two decades. CROs have established their role in filling manpower shortages, relieving pressure on drug sponsor staff and expanding into new geographical areas and therapeutic fields. Yet there remains much dissatisfaction with the transaction on both sides. Why is this?...